McDonald’s AI Pricing Lawsuit Tests New Ground in US Antitrust Law
McDonald’s faces a proposed class action alleging its AI pricing technology enabled coordinated menu pricing, raising new questions under US antitrust law.
Category: Antitrust
Apple and Amazon Face Revived UK Consumer Claim Over Product Sales
Apple and Amazon face a revived UK collective claim alleging 2018 marketplace restrictions raised prices for Apple products sold through Amazon.
US Judge Dismisses Michigan Climate Antitrust Lawsuit Against BP, Chevron, Exxon and Shell
A US judge dismisses Michigan’s antitrust lawsuit against BP, Chevron, Exxon, Shell and API, finding the alleged injuries too remote from the claimed conspiracy.
EU Antitrust Raids Ferrero: What Cross-Border Sales Rules Mean for Businesses
EU antitrust raids Ferrero raise urgent questions over cross-border sales rules and compliance risks for businesses operating in the EU.
$87.5 Million Tyson and Cargill Beef Antitrust Settlement Exposes the Price of Market Power
Tyson Foods and Cargill’s $87.5M antitrust settlement over wholesale beef pricing signals growing institutional liability and supply chain trust risks.
WNBA vs. Project B: The $5 Billion Legal and Antitrust Showdown
Project B, backed by ex-Skype/Facebook execs, promises $2M salaries & equity. We break down the $5B legal threat to the WNBA & risks from…
FTC Case Hits Ticketmaster for $3.7B Resale Fees and Deceptive Pricing
FTC accuses Ticketmaster of profiting $3.7B from illegal resales and deceptive fees, testing consumer protection law in court.
Texas’ Coal Lawsuit Against BlackRock, Vanguard, and State Street Presses On
Texas’ antitrust case against BlackRock, Vanguard, and State Street over coal restrictions survives dismissal and heads deeper into court.
Baker McKenzie Advises Unilever in Dr. Squatch Acquisition
Baker McKenzie advised Unilever on its acquisition of men’s care brand Dr. Squatch, expanding its global personal care portfolio.
White & Case Wins $405M Antitrust Case for Regeneron
White & Case secures $405M jury win for Regeneron in antitrust case, with Amgen found liable for anti-competitive bundling tactics.